{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:11:05Z","timestamp":1788480665694,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s10157-021-02067-y","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T08:04:04Z","timestamp":1619597044000},"page":"935-943","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hepatocyte growth factor ameliorates methylglyoxal-induced peritoneal inflammation and fibrosis in mouse model"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9148-1940","authenticated-orcid":false,"given":"Haruhito","family":"Yoshimine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiroh","family":"Tanoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaro","family":"Ibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Kanmura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Ido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,28]]},"reference":[{"key":"2067_CR1","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0140-6736(16)30448-2","volume":"388","author":"BM Robinson","year":"2016","unstructured":"Robinson BM, et al. Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices. Lancet. 2016;388:294\u2013306.","journal-title":"Lancet"},{"key":"2067_CR2","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1046\/j.1523-1755.2003.00265.x","volume":"64","author":"LW Morgan","year":"2003","unstructured":"Morgan LW, et al. Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration. Kidney Int. 2003;64:1854\u201366.","journal-title":"Kidney Int"},{"key":"2067_CR3","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1681\/ASN.V132470","volume":"13","author":"JD Williams","year":"2002","unstructured":"Williams JD, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol. 2002;13:470\u20139.","journal-title":"J Am Soc Nephrol"},{"key":"2067_CR4","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1681\/ASN.V12112434","volume":"12","author":"J Witowski","year":"2001","unstructured":"Witowski J, et al. Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells. J Am Soc Nephrol. 2001;12:2434\u201341.","journal-title":"J Am Soc Nephrol"},{"key":"2067_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1681\/ASN.2004060436","volume":"16","author":"PJ Margetts","year":"2005","unstructured":"Margetts PJ, et al. Transient overexpression of TGF-\u03b21 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol. 2005;16:425\u201336.","journal-title":"J Am Soc Nephrol"},{"key":"2067_CR6","first-page":"406","volume":"232","author":"AH Thomas","year":"2007","unstructured":"Thomas AH, et al. Collagen fragments modulate innate immunity. Exp Biol Med (Maywood). 2007;232:406\u201311.","journal-title":"Exp Biol Med (Maywood)"},{"key":"2067_CR7","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","volume":"331","author":"FH Epstein","year":"1994","unstructured":"Epstein FH, et al. Transforming growth factor \u03b2 in tissue fibrosis. N Engl J Med. 1994;331:1286\u201392.","journal-title":"N Engl J Med"},{"key":"2067_CR8","first-page":"50","volume":"32","author":"M Padwal","year":"2017","unstructured":"Padwal M, et al. Matrix metalloproteinase 9 is associated with peritoneal membrane solute transport and induces angiogenesis through \u03b2-catenin signaling. Nephrol Dial Transplant. 2017;32:50\u201361.","journal-title":"Nephrol Dial Transplant"},{"key":"2067_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.immuni.2013.10.022","volume":"40","author":"CA Fielding","year":"2014","unstructured":"Fielding CA, et al. Interleukin-6 signaling drives fibrosis in unresolved inflammation. Immunity. 2014;40:40\u201350.","journal-title":"Immunity"},{"key":"2067_CR10","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.kint.2016.03.040","volume":"90","author":"Q Zhou","year":"2016","unstructured":"Zhou Q, et al. Preventing peritoneal membrane fibrosis in peritoneal dialysis patients. Kidney Int. 2016;90:515\u201324.","journal-title":"Kidney Int"},{"key":"2067_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.molimm.2017.12.023","volume":"94","author":"Q Li","year":"2018","unstructured":"Li Q, et al. A pathogenetic role for M1 macrophages in peritoneal dialysis-associated fibrosis. Mol Immunol. 2018;94:131\u20139.","journal-title":"Mol Immunol"},{"key":"2067_CR12","doi-asserted-by":"publisher","first-page":"e0160993","DOI":"10.1371\/journal.pone.0160993","volume":"11","author":"T Nagai","year":"2016","unstructured":"Nagai T, et al. Linagliptin ameliorates methylglyoxal-induced peritoneal fibrosis in mice. PLoS ONE. 2016;11:e0160993.","journal-title":"PLoS ONE"},{"key":"2067_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cbi.2011.11.002","volume":"195","author":"M Kitamura","year":"2012","unstructured":"Kitamura M, et al. Epigallocatechin gallate suppresses peritoneal fibrosis in mice. Chem Biol Interact. 2012;195:95\u2013104.","journal-title":"Chem Biol Interact"},{"key":"2067_CR14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/ndt\/gfn495","volume":"24","author":"I Hirahara","year":"2009","unstructured":"Hirahara I, et al. Methylglyoxal induces peritoneal thicking by mesenchymal-like mesothelial cells in rats. Nephrol Dial Transplant. 2009;24:437\u201347.","journal-title":"Nephrol Dial Transplant"},{"key":"2067_CR15","doi-asserted-by":"publisher","first-page":"41901","DOI":"10.1038\/srep41901","volume":"7","author":"I Nita","year":"2017","unstructured":"Nita I, et al. Hepatocyte growth factor secreted by bone marrow stem cell reduce ER stress and improves repair in alveolar epithelial II cells. Sci Rep. 2017;7:41901.","journal-title":"Sci Rep"},{"key":"2067_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1159\/000491876","volume":"99","author":"Y Komaki","year":"2019","unstructured":"Komaki Y, et al. Hepatocyte growth factor facilitates esophageal mucosal repair and inhibits the submucosal fibrosis in a rat model of esophageal ulcer. Digestion. 2019;99:227\u201338.","journal-title":"Digestion"},{"key":"2067_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12659\/AOT.906700","volume":"23","author":"Z Wang","year":"2018","unstructured":"Wang Z, et al. Antifibrotic effects of hepatocyte growth factor on endothelial-to-mesenchymal transition via transforming growth factor-betal(TGF-\u03b21)\/smad and Akt\/mTOR\/P70S6K signaling pathways. Ann Transplant. 2018;23:1\u201310.","journal-title":"Ann Transplant"},{"key":"2067_CR18","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.celrep.2017.03.066","volume":"19","author":"JT Rodgers","year":"2017","unstructured":"Rodgers JT, et al. HGFA is an injury-regulated systemic factor that induces the transition of stem cells into GAlert. Cell Rep. 2017;19:479\u201386.","journal-title":"Cell Rep"},{"key":"2067_CR19","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1681\/ASN.2008040424","volume":"20","author":"MA Yu","year":"2009","unstructured":"Yu MA, et al. HGF and BMP-7 ameliorate high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesothelium. J Am Soc Nephrol. 2009;20:567\u201381.","journal-title":"J Am Soc Nephrol"},{"key":"2067_CR20","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1172\/JCI119885","volume":"101","author":"M Shinohara","year":"1998","unstructured":"Shinohara M, et al. Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest. 1998;101:1142\u20137.","journal-title":"J Clin Invest"},{"key":"2067_CR21","doi-asserted-by":"publisher","DOI":"10.1096\/fj.04-1535fje","author":"S Mizuno","year":"2005","unstructured":"Mizuno S, et al. HGF reduces advancing lung fibrosis in mice: a potential role for MMP-dependent myofibroblast apoptosis. FASEB J. 2005. https:\/\/doi.org\/10.1096\/fj.04-1535fje.","journal-title":"FASEB J"},{"key":"2067_CR22","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1046\/j.1523-1755.2001.0590041304.x","volume":"59","author":"S Mizuno","year":"2001","unstructured":"Mizuno S, et al. Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy. Kidney Int. 2001;59:1304\u201314.","journal-title":"Kidney Int"},{"key":"2067_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbrc.2009.05.010","volume":"385","author":"S Schievenbusch","year":"2009","unstructured":"Schievenbusch S, et al. Profiling of anti-fibrotic signaling by hepatocyte growth factor in renal fibroblasts. Biochem Biophys Res Commun. 2009;385:55\u201361.","journal-title":"Biochem Biophys Res Commun"},{"key":"2067_CR24","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1681\/ASN.2013101079","volume":"25","author":"YT Chen","year":"2014","unstructured":"Chen YT, et al. Lineage tracing reveals distinctive fates for mesothelial cells and submesothelial fibroblasts during peritoneal injury. J Am Soc Nephrol. 2014;25:2847\u201358.","journal-title":"J Am Soc Nephrol"},{"key":"2067_CR25","doi-asserted-by":"publisher","first-page":"105845","DOI":"10.1016\/j.intimp.2019.105845","volume":"76","author":"X Zhang","year":"2019","unstructured":"Zhang X, et al. Type I collagen or gelatin stimulates mouse peritoneal macrophages to aggregate and produce pro-inflammatory molecules through upregulated ROS levels. Int Immunopharmacol. 2019;76:105845.","journal-title":"Int Immunopharmacol"},{"key":"2067_CR26","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1046\/j.1523-1755.2003.00861.x","volume":"63","author":"AH Yang","year":"2003","unstructured":"Yang AH, et al. Myofibroblastic conversion of mesothelial cells. Kidney Int. 2003;63:1530\u20139.","journal-title":"Kidney Int"},{"key":"2067_CR27","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/sj.gt.3302740","volume":"13","author":"J Azuma","year":"2006","unstructured":"Azuma J, et al. Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy. Gene Ther. 2006;13:1206\u201313.","journal-title":"Gene Ther"},{"key":"2067_CR28","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3747\/pdi.2014.00125","volume":"35","author":"S Yung","year":"2015","unstructured":"Yung S, et al. Impact of a low-glucose peritoneal dialysis regimen on fibrosis and inflammation biomarkers. Perit Dial Int. 2015;35:147\u201358.","journal-title":"Perit Dial Int."},{"key":"2067_CR29","first-page":"64","volume":"21","author":"T Matsuoka","year":"2008","unstructured":"Matsuoka T, et al. Hepatocyte growth factor prevents peritoneal fibrosis in an animal model of encapsulating peritoneal sclerosis. J Nephrol. 2008;21:64\u201373.","journal-title":"J Nephrol"},{"key":"2067_CR30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.hepres.2004.09.002","volume":"30","author":"A Ido","year":"2004","unstructured":"Ido A, et al. Pharmacokinetic study of recombinant human hepatocyte growth factor administered in a bolus intravenously or via portal vein. Hepatol Res. 2004;30:175\u201381.","journal-title":"Hepatol Res"},{"key":"2067_CR31","first-page":"250","volume":"16","author":"D Jiang","year":"2010","unstructured":"Jiang D, et al. Protective action of hepatocyte growth factor on transforming growth factor \u03b2-1-induced \u03b1-smooth muscle actin and extracellular matrix in cultured human peritoneal fibroblasts. Case Reports Clin Pract Rev. 2010;16:250\u20134.","journal-title":"Case Reports Clin Pract Rev"},{"key":"2067_CR32","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.3892\/mmr.2017.6166","volume":"15","author":"HA Lee","year":"2017","unstructured":"Lee HA, et al. Ethyl acetate extract from Asparagus cochinchinensis exerts anti-inflammatory effects in LPS-stimulated RAW264.7 macrophage cells by regulating COX-2\/iNOS, inflammatory cytokine expression, MAP kinase pathways, the cell cycle and anti-oxidant activity. Mol Med Rep. 2017;15:1613\u201323.","journal-title":"Mol Med Rep."},{"key":"2067_CR33","doi-asserted-by":"publisher","first-page":"13435","DOI":"10.1523\/JNEUROSCI.3257-09.2009","volume":"29","author":"KA Kigerl","year":"2009","unstructured":"Kigerl KA, et al. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci. 2009;29:13435\u201344.","journal-title":"J Neurosci"},{"key":"2067_CR34","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.yexmp.2014.04.003","volume":"96","author":"KK Wijesundera","year":"2014","unstructured":"Wijesundera KK, et al. M1- and M2-macrophage polarization in rat liver cirrhosis induced by thioacetamide (TAA), focusing on Iba1 and galectin-3. Exp Mol Pathol. 2014;96:382\u201392.","journal-title":"Exp Mol Pathol"},{"key":"2067_CR35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.intimp.2017.10.013","volume":"54","author":"S Chen","year":"2018","unstructured":"Chen S, Lu Z, et al. Cathelicidin-WA polarizes E. coli K88-induced M1 macrophage to M2-like macrophage in RAW264.7 cells. Int Immunopharmacol. 2018;54:52\u20139.","journal-title":"Int Immunopharmacol."},{"key":"2067_CR36","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1631\/jzus.B1700003","volume":"18","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, et al. Comparison of the characteristics of macrophages derived from murine spleen, peritoneal cavity, and bone marrow. J Zhejiang Univ Sci B. 2017;18:1055\u201363.","journal-title":"J Zhejiang Univ Sci B"},{"key":"2067_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1023\/A:1020288911885","volume":"23","author":"NC Mlambo","year":"1999","unstructured":"Mlambo NC, et al. Increased levels of transforming growth factor beta 1 and basic fibroblast growth factor in patients on CAPD: a study during non-infected steady state and peritonitis. Inflammation. 1999;23:131\u20139.","journal-title":"Inflammation"},{"key":"2067_CR38","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1093\/ndt\/gfq771","volume":"26","author":"T Bell\u00f3n","year":"2011","unstructured":"Bell\u00f3n T, et al. Alternative activation of macrophages in human peritoneum: implications for peritoneal fibrosis. Nephrol Dial Transplant. 2011;26:2995\u20133005.","journal-title":"Nephrol Dial Transplant"},{"key":"2067_CR39","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.1182\/blood.V95.12.3964.012k20_3964_3969","volume":"95","author":"M Beilmann","year":"2000","unstructured":"Beilmann M, Vande Woude GF, Dienes HP, Schirmacher P. Hepatocyte growth factor-stimulated invasiveness of monocytes. Blood. 2000;95:3964\u20139.","journal-title":"Blood"},{"key":"2067_CR40","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1046\/j.1365-2249.2001.01591.x","volume":"125","author":"Q Jiang","year":"2001","unstructured":"Jiang Q, et al. Differential responsiveness of cord and adult blood monocytes to hepatocyte growth factor. Clin Exp Immunol. 2001;125:222\u20138.","journal-title":"Clin Exp Immunol"},{"key":"2067_CR41","first-page":"821","volume":"7","author":"Q Chen","year":"1996","unstructured":"Chen Q, et al. Induction of met proto-oncogene (hepatocyte growth factor receptor) expression during human monocyte-macrophage differentiation. Cell Growth Differ. 1996;7:821\u201332.","journal-title":"Cell Growth Differ"},{"key":"2067_CR42","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.4049\/jimmunol.166.2.1241","volume":"166","author":"F Galimi","year":"2001","unstructured":"Galimi F, et al. Hepatocyte growth factor is a regulator of monocyte- macrophage function. J Immunol. 2001;166:1241\u20137.","journal-title":"J Immunol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-021-02067-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-021-02067-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-021-02067-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T11:03:58Z","timestamp":1628766238000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-021-02067-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,28]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["2067"],"URL":"https:\/\/doi.org\/10.1007\/s10157-021-02067-y","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,28]]},"assertion":[{"value":"30 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflicts of interest exist.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving animals were in accordance with the Kagoshima University Animal Experiment Rules. This article does not contain any studies with human participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}}]}}